Autoimmune systemic diseases (ASD) show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed at evaluating the …

Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

The COVID-19 pandemic has quickly become the most significant public health
phenomenon, effectively eclipsing the H1N1 and Ebola crises that came before it. It can …

Background: Reports describing post-vaccine autoimmune phenomena, in previously
healthy individuals, increased the concerns regarding the risk of disease flare-ups in …

Background Data are scarce on immunogenicity of COVID-19 vaccines in patients with
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …

Patients with autoimmune diseases are among the susceptible groups to COVID-19
infection because of the complexity of their conditions and the side effects of the …

Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 670 million infections and …

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) became a
major concern since the announcement that it is a pandemic in early 2020. Vaccine trials …

Objective to investigate the responses to mRNA COVID-19 vaccines in a cohort of
immunosuppressed patients affected by immune-mediated inflammatory diseases (IMID) …